ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2026
Why Product Drift Is Not an Issue for Biosimilars/Biologics: Start the Same, Stay the Same.
Joseph P Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.